gained rapidly. At 20, she weighed 1II st but dieting reduced this to 10 st. Soon afterwards she married, and within a few weeks her weight was 9 st. During this time, she had had normal menstruation. Conception occurred soon after marriage and, at the end of her first pregnancy, she weighed only 8 st 8 lb. She failed to menstruate but, on gaining 10 lb in weight, she conceived again. By the end of that pregnancy she again weighed only 8 st 8 lb, at which figure her weight remained (correct weight for her height, 5 ft 71 in., about 9 st 12 lb). Since the second pregnancy, she had had no spontaneous periods but hormone treatments had caused withdrawal bleedings. When I saw her, she was obviously a mild case of anorexia nervosa, with the typical downy lanugo hair, very small uterus and loss of vaginal rugn. She was persuaded to eat more and, within three months, her weight had increased to 9 st 0I lb. A spontaneous period occurred soon after and, as judged by her basal temperature record, ovulation took place about five weeks later, leading to conception.
The same kind of response to weight adjustment may sometimes be seen in overweight patients.
No further reference will be made to adrenal hyperplasia and to the Stein-Leventhal syndrome, fascinating though these disorders may be -partly because their importance is becoming more widely appreciated. What follows will be confined to disorders of ovulation without obvious endocrine cause, under which heading mention will be made of some of the oldest as well as the latest approaches to the problem of induction of ovulation.
Disorders of Ovulation without Obvious Endocrine Cause
Most of the patients fall into this group. They show no evidence of pituitary, thyroid or adrenal abnormality and commonly complain of oligomenorrhea or secondary amenorrhoea; less often, while under investigation for infertility, they are found to have more or less regular but anovular cycles. In not a few, emotional factors -more or less obvious -are important in the aetiology. Among the older methods used for inducing ovulation are cyclic treatment with cestrogens and progestagens, and low dosage pituitary and ovarian irradiation; brief reference will be made to some personal experience with these forms of treatment. The use of gonadotrophins is now of some antiquity, but there have also been some striking recent developments. Finally, and most recent of all, is the possibility of inducing ovulation by chemical means.
Some twelve or thirteen years ago, I published details of a method of oral hormonal therapy for menstrual disorders (Swyer 1949 (Swyer , 1950 which was a modification of that described by Hamblen (1945 Case 2 Aged 27. Irregular, intermenstrual spotting gradually developing into prolonged irregular and excessive bleeding over six months. Bleeding easily controlled with stilbeestrol 5 mg daily and regular cycles followed a combined oestrogen and ethisterone course at constant dosage. A biopsy taken before the second spontaneous period showed proliferative endometrium. Shortly afterwards, she relapsed and dilatation and curettage were performed because of the severity of the bleeding. Subsequent treatment with a decreasing cestrogen, increasing progestagen course led to the re-establishment of normal ovular cycles.
In the original report (Swyer 1949 Further treatment with cestrogens and progestagens over a period of two-and-a-half years was eventually followed by regular spontaneous ovular cycles and in the following year (1952) Fertility and Sterility (1958, 9, 178) . At University College Hospital we abandoned therapeutic irradiation of the ovaries several years ago, but continued to use pituitary irradiation alone on a small selected series of patients for a time, though this too has since been abandoned.
Data are available, however, on a series of 44' patients who received pituitary and ovarian irradiation, following the technique described by Williams (1953) . Of these patients, 6 had longstanding secondary amenorrhea and all showed no response; 19 patients had anovular cycleseither sometimes or, apparently, all the time; and 19 patients forned a miscellaneous group who had either irregular but ovular cycles, oligomenorrhcea but with ovulation, or, a somewhat unsatisfactory label, 'suspected abnormal ovulation'. Pregnancy occurred in 17 patients, that is, in 50% of those patients who did not have secondary amenorrhoea. In addition, regular menstruation followed treatment in a further 3 patients who had had irregular cycles.
The 5 patients treated by irradiation of the pituitary alone showed little response. Only one has conceived, and since this happened more than a year after treatment, it is unlikely to have been the result of it.
Gonadotrophin Therapy for the
Induction of Ovulation
It is clear that the only cases in which gonadotrophin therapy can be expected to lead to ovulation are those whose ovaries contain follicles capable of responding to appropriate stimulation. The main problem has been availability of effective gonadotrophin preparations.
Human chorionic gonadotrophin: Historically, human chorionic gonadotrophin (HCG) has pride of place, its discovery in the urine of pregnant women by Aschheim & Zondek dating back to 1927. Because it is readily available and easily prepared in a form suitable for human administration which is well tolerated, it has been used extensively and many of the older workers have claimed that it can induce ovulation and cause corpus luteum formation in women (for references, see' the excellent review of Kotz & Herrmann 1961) . Other workers, however, have denied these results and have believed that HCG is not only without power to stimulate primate Graafian follicles and to liberate their ova, but may also cause follicle atresia, hyalinization and decreased ovarian secretion.
In Scandinavia, on the other hand, interest in HCG has been maintained and reports of its successful use have continued to appear. These workers, including Bergman (1958) , Pahlson (1951) , Rydberg (1943) and Wahlen (1952) have shown that, in patients with metropathia himorrhagica, a high success rate is possible. The point is made that, for HCG to be effective, the ovaries must contain more or less mature follicles -as they usually do in women with metropathia hemorrhagica. In such cases, Wahlen found evidence of ovulation, as judged by basal temperature records and endometrial biopsies, in 83% of 46 women; and Bergman in 82% of 110 women less than 45 years of age in whom anovulation had persisted after curettage. In the latter series, 24 patients had 32 pregnancies during or following treatment. The usual dosage was 1,500 i.u. intramuscularly on three consecutive days.
Serum gonadotrophin: The existence of a gonadotrophin in pregnant mares' serum was discovered by Cole & Hart in 1930 . This substance (PMS) has been shown to possess predominantly follicle-stimulating properties, though it is not entirely free from luteinizing hormone (LH) activity. Numerous reports (see Kotz & Herrmann 1961) have shown that PMS is capable of inducing follicle development, ovulation and corpus luteum formation, not only in hypophysectomized animals but also in intact mice, ewes, sows, cows and rabbits. There have also been numerous studies in human beings. As long ago as 1937, Westman found that 9,000-10,000 mouse units stimulated follicle development and that higher dosages could cause cystic changes, but corpora lutea were not produced. Other observers noted similar findings but stated that luteinization of the theca interna, and occasionally of the granulosa, occurred. Although several workers claimed to have induced ovulation in women with PMS alone, most of the papers on the human give disappointing and inconsistent results. The use of PMS to stimulate follicle development, followed by HCG to induce ovulation and luteinization, seems a logical approach and has been advocated by Hamblen & Davis (1945) , Rydberg (1943) and Riisfeldt (1949) . On the whole, the results with this procedure have been found by most workers to be more encouraging than with uncombined therapy. The impression gained is that for PMS alone to induce ovulation, there must be sufficient LH production by the patient's own pituitary, while for HCG alone to do so, mature follicles must be present.
The 'one-two' procedure of Hamblen consists in giving 400 i.u. of PMS daily for ten days, followed by 300 i. Gemzell (1961 Gemzell ( , 1962 and by Buxton & Herrmann (1961) for the induction of ovulation in women with results of the greatest importance.
Humanpituitary gonadotrophin: The most interesting chapter in the story of gonadotrophin therapy for inducing ovulation in women covers the work of Gemzell and of Buxton & As an alternative explanation of the effect of the administered FSH causing multiple follicle stimulation, Gemzell (1962) (Fig 1) .
One of these, PB, aged 23, had primary amenorrhoea and presented a somewhat infantilistic appearance, but investigation excluded panhypopituitarism and ovarian biopsy (at the time of operation for chronic appendicitis) showed follicle cysts and primordial and atretic follicles, thus excluding gonadal dysgenesis. The small ovaries (measuring 1 x 1 cm) were therefore compatible with selective gonadotrophin deficiency. The other patient, ES, aged 22, had had a single spontaneous period at the age of 18. Thyroid and adrenal function were normal but the vaginal smear was atrophic (in contrast to PB, whose vaginal smear did not show gross cestrogen deficiency).
Both patients were given 250 E units of HMG twice daily for four days but as the cervical mucus showed no increase and the vaginal smear little change, the dose was then doubled, the injections being continued for six more days, following which HCG 3,000 units daily was given for three days. There was a small rise in the pyknotic index of the vaginal smear of ES during HMG treatment but it did not reach anything like normal proliferative phase levels; in PB the changes were insignificant. The urinary cestrogens rose in both cases, but the rise was not maintained. Urinary pregnanediol, pregnanetriol, -ketosteroids and ketogenic steroids showed no significant changes. In these patients, therefore, one at least of whom had ovaries which, on histological grounds, should have been capable of reacting, there was no convincing response to treatment with HMG at the dose level used.
Clomiphene
The possibility of inducing ovulation in the human by chemical means has recently been brought into prominence by reports on the effects of two diethylaminoethoxy-phenyl compounds, related to the synthetic pro-estrogen chlorotrianisene. One of these, MER-25 or l-(p-2-diethylaminoethoxy phenyl)-l-phenyl-2-panisylethanol, has been given to 4 patients with the Stein-Leventhal syndrome by Kistner & Smith (1961) who found that ovulation promptly followed its administration in low dosage, though more prolonged treatment at higher dosage in 3 older patients with endometrial hyperplasia gave evidence of cestrogen antagonism.
Experimental studies (Nelson 1961) , seem to indicate that MER-25 may interfere in the development of eggs in sea urchins and in rabbits and rats, though in these latter species only during the passage down the tube, and so be an antifertility agent. This property appears to be shared by the other compound, 1-(p-2-diethylaminoethoxy phenyl)-l, 2-diphenyl-2-chloroethylene or clomiphene (also known as MRL/41 and chloramiphene), for Holtkamp et al. (1961) found it to have gonadotrophininhibiting and antifecundity effects in rats. In women, on the other hand, Greenblatt (1961) and Greenblatt et al. (1961) The results of these studies will be published in detail; here, only a brief summary can be given. The basal temperature record was biphasic in about 50% of cycles, the thermal shift occurring at a mean of 13-5 days after starting treatment. Clearly, clomiphene is not itself thermogenic. The thermal response lasted for a mean of fifteen days, so the pattern would seem to be compatible with that which might result from the induction of a functioning corpus luteum. Pregnanediol excretion was raised -up to 9-7 mg/24 hours -in about 70% of cycles. Endometrial biopsies showed hypoplastic, proliferative and early secretory patterns. (Estrogen excretion showed marked elevation, especially of the oestrone fraction, in some cycles. A maximum of over 1,000 ,ug/24 hours was recorded. On the other hand, pregnanetriol, 1 7-ketosteroid and 1 7-ketogenic steroid excretion showed little change in most cases. In a recent case, suspected of having gonadal dysgenesis, no hormonal response at all was seen.
It may be that clomiphene treatment has stimulated ovarian activity, perhaps with the induction of ovulation, in some of our cases but it is important to note that convincing evidence, such as the presence of a biphasic temperature record together with a rise in pregnanediol output and the development of a secretory endometrium, all at the same time has, in general, been lacking. In only 2 cases was such a combination found, and even in these, the endometrial development did not show advanced secretory changes. These 
